Unlike conventional autorefractors, QuickSee uses wavefront aberrometry to precisely determine low-order refractive errors, enabling highly accurate, objective measurements anywhere.
And because of its compact design and fast, accurate measurements, QuickSee can streamline your clinical workflow, declutter your practice environment, and improve your patients’ experience.
Its combination of the open view binocular design, wavefront aberrometry, and dynamic measurements produce clinically accurate autorefraction measurements, in a durable handheld format suitable for use in clinics and in the field.
Wavefront autorefraction powered by the patented PlenOptika Wavefront Refraction Engine™ performs continuous data analysis to precisely determine low-order refractive errors, makes QuickSee is as accurate as the high-end clinical desktop autorefractors and demonstrates excellent agreement with subjective refraction.
The technology inside QuickSee has been clinically-evaluated in five IRB-based studies and documented in five peer-reviewed publications and conference abstracts. QuickSee has FDA Class I 510(k) exempt medical device registration.